All Stories

  1. Caged Oxime Reactivators Designed for the Light Control of Acetylcholinesterase Reactivation †
  2. Nanomaterial-Enabled Sensors and Therapeutic Platforms for Reactive Organophosphates
  3. Dual acting oximes designed for therapeutic decontamination of reactive organophosphates via catalytic inactivation and acetylcholinesterase reactivation
  4. Activation Strategies in Image-Guided Nanotherapeutic Delivery
  5. Photoactivation Strategies for Therapeutic Release in Nanodelivery Systems
  6. Shielded α-Nucleophile Nanoreactor for Topical Decontamination of Reactive Organophosphate
  7. Multifunctional therapeutic strategy of Ag-synergized dual-modality upconversion nanoparticles to achieve the rapid and sustained cidality of methicillin-resistant Staphylococcus aureus
  8. Spacer-Mediated Control of Coumarin Uncaging for Photocaged Thymidine
  9. Photonanotechnology for Therapeutics and Imaging
  10. Photocleavable linkers
  11. Front Matter
  12. Photocontrolled nanosystems for antibacterial drug delivery
  13. Light sources for photonanotechnology
  14. Photocontrolled nanosystems for antitumor drug delivery
  15. Hydrophilic scaffolds of oxime as the potent catalytic inactivator of reactive organophosphate
  16. Reactivity and mechanism of α-nucleophile scaffolds as catalytic organophosphate scavengers
  17. Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)
  18. Measuring the Adhesion Forces for the Multivalent Binding of Vancomycin-Conjugated Dendrimer to Bacterial Cell-Wall Peptide
  19. Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via Its Bivalent Motifs of Interaction
  20. Lanthanide-doped core–shell nanoparticles as a multimodality platform for imaging and photodynamic therapy
  21. Photocontrolled Release of Doxorubicin Conjugated through a Thioacetal Photocage in Folate-Targeted Nanodelivery Systems
  22. Ligand Characteristics Important to Avidity Interactions of Multivalent Nanoparticles
  23. Control of an Unusual Photo-Claisen Rearrangement in Coumarin Caged Tamoxifen through an Extended Spacer
  24. Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity
  25. Yolk-structured multifunctional up-conversion nanoparticles for synergistic photodynamic–sonodynamic antibacterial resistance therapy
  26. Riboflavin-Conjugated Multivalent Dendrimer Platform for Cancer-Targeted Drug and Gene Delivery
  27. Inside Cover: A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging (ChemBioChem 1/2017)
  28. A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging
  29. Mechanistic basis of light induced cytotoxicity of photoactive nanomaterials
  30. Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugates
  31. Mechanism of Cooperativity and Nonlinear Release Kinetics in Multivalent Dendrimer–Atropine Complexes
  32. Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release
  33. Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
  34. Force Spectroscopy of Multivalent Binding of Riboflavin-Conjugated Dendrimers to Riboflavin Binding Protein
  35. Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery
  36. A lipopolysaccharide binding heteromultivalent dendrimer nanoplatform for Gram negative cell targeting
  37. 4-Hydroxytamoxifen probes for light-dependent spatiotemporal control of Cre-ER mediated reporter gene expression
  38. Multivalent Dendrimer Vectors with DNA Intercalation Motifs for Gene Delivery
  39. Poly(amidoamine) Dendrimer–Methotrexate Conjugates: The Mechanism of Interaction with Folate Binding Protein
  40. Evaluating Binding Avidities of Populations of Heterogeneous Multivalent Ligand-Functionalized Nanoparticles
  41. Avidity Mechanism of Dendrimer–Folic Acid Conjugates
  42. Atomic Force Microscopy Probing of Receptor–Nanoparticle Interactions for Riboflavin Receptor Targeted Gold–Dendrimer Nanocomposites
  43. Design and mechanistic investigation of oxime-conjugated PAMAM dendrimers as the catalytic scavenger of reactive organophosphate
  44. Avidity Modulation of Folate-Targeted Multivalent Dendrimers for Evaluating Biophysical Models of Cancer Targeting Nanoparticles
  45. DNA Condensation by Partially Acetylated Poly(amido amine) Dendrimers: Effects of Dendrimer Charge Density on Complex Formation
  46. Design and In vitro Validation of Multivalent Dendrimer Methotrexates as a Folate-targeting Anticancer Therapeutic
  47. Paclitaxel-Conjugated PAMAM Dendrimers Adversely Affect Microtubule Structure through Two Independent Modes of Action
  48. Dendrimer-Based Multivalent Vancomycin Nanoplatform for Targeting the Drug-Resistant Bacterial Surface
  49. Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification
  50. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation
  51. Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic
  52. Specific and Cooperative Interactions between Oximes and PAMAM Dendrimers As Demonstrated by 1 H NMR Study
  53. Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749
  54. Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate
  55. Biophysical Characterization of a Riboflavin-Conjugated Dendrimer Platform for Targeted Drug Delivery
  56. A photochemical approach for controlled drug release in targeted drug delivery
  57. Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
  58. A multivalent approach to the discovery of long-acting β2-adrenoceptor agonists for the treatment of asthma and COPD
  59. Specificity and Negative Cooperativity in Dendrimer–Oxime Drug Complexation
  60. Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery—A Thermodynamic and Kinetic Study
  61. Characterizing Riboflavin Antagonists for Targeted Drug Delivery Applications
  62. Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery
  63. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate
  64. Progress in Cancer Nanotechnology
  65. A Multivalent Approach to the Design and Discovery of Orally Efficacious 5-HT 4 Receptor Agonists
  66. Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers
  67. Designing Selective, High Affinity Ligands of 5-HT 1D Receptor by Covalent Dimerization of 5-HT 1F Ligands Derived From 4-Fluoro- N -[3-(1-methyl-4-piperidinyl)-1 H -indol-5-yl]benzamide
  68. Synthetic Multivalent Molecules: Concepts and Biomedical Applications. By Seok-Ki Choi.
  69. Synthetic Multivalent Molecules
  70. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds
  71. Optically controlled collisions of biological objects
  72. Structure-binding relation of philanthotoxins from nicotinic acetylcholine receptor binding assay
  73. Generation and in Situ Evaluation of Libraries of Poly(acrylic acid) Presenting Sialosides as Side Chains as Polyvalent Inhibitors of Influenza-Mediated Hemagglutination
  74. Optically controlled collisions of biological objects to evaluate potent polyvalent inhibitors of virus-cell adhesion
  75. Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups
  76. Synthesis of C-5 Analogs of N -Acetylneuraminic Acid via Indium-Mediated Allylation of N-Substituted 2-Amino-2-deoxymannoses
  77. The action of philanthotoxin-343 and photolabile analogues on locust (Schistocerca gregaria) muscle
  78. Labeling studies of photolabile philanthotoxins with nicotinic acetylcholine receptors: mode of interaction between toxin and receptor
  79. Bioorganic studies of transmitter receptors with philanthotoxin analogs
  80. Synthesis and assay of hybrid analogs of argiotoxin-636 and philanthotoxin-433: glutamate receptor antagonists
  81. Synthesis of novel and photolabile philanthotoxin analogs: Glutamate receptor antagonists